<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/B7B056A3-95CE-4F90-9F31-708B4612610D"><gtr:id>B7B056A3-95CE-4F90-9F31-708B4612610D</gtr:id><gtr:name>The Genome Analysis Centre</gtr:name><gtr:department>UNLISTED</gtr:department><gtr:address><gtr:line1>Norwich Research Park</gtr:line1><gtr:line2>Colney</gtr:line2><gtr:postCode>NR4 7UH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B7B056A3-95CE-4F90-9F31-708B4612610D"><gtr:id>B7B056A3-95CE-4F90-9F31-708B4612610D</gtr:id><gtr:name>The Genome Analysis Centre</gtr:name><gtr:address><gtr:line1>Norwich Research Park</gtr:line1><gtr:line2>Colney</gtr:line2><gtr:postCode>NR4 7UH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/DB9BB398-0F46-4411-873D-9DCF3076B6BA"><gtr:id>DB9BB398-0F46-4411-873D-9DCF3076B6BA</gtr:id><gtr:firstName>Wiktor</gtr:firstName><gtr:otherNames>Andrzej</gtr:otherNames><gtr:surname>Jurkowski</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BBS%2FE%2FT%2F000GP023"><gtr:id>A1326458-BE04-4AD2-B1D6-1AF0FAC4118B</gtr:id><gtr:title>Renewable Industrial Products from Rapeseed (RIPR)</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>BBS/E/T/000GP023</gtr:grantReference><gtr:abstractText>Oilseed rape is commercially viable because a co-product can be exploited (a protein-rich feed for animals) in addition to the primary product (oil). However, many other valuable products could be extracted and exploited commercially, adding value to the crop. The serial purification of co-products is termed &amp;quot;bio-refining&amp;quot;. Emerging opportunities include tocopherols (vitamin E) and phytosterols (cholesterol lowering compounds) from rapeseed oil, waxes (with aphid-repellent properties and those with medical properties) from pod walls and stems, and functional polysaccharides (including high-value stabilisers, surfactants and barriers) from stems. Additionally, the efficiency with which fertilizer is used by rapeseed is poorly understood, but its optimization is essential as fertilizer is both expensive and potentially damaging to the environment.

Recent advances in sequencing technology and genomics has led to the emergence of a technology termed Associative Transcriptomics. In this approach, the search for DNA sequence variation is focussed on gene sequences and variation for gene expression is also exploited; both providing very large sets of potential &amp;quot;markers&amp;quot; for trait variation. This project will sequence the transcriptome of 600 diverse Brassica accessions (100 B. rapa, 100 B. oleracea and 400 B.napus from the ASSYST diversity panel). Sequence data, genetic variants and expression data will be stored in a publicly accessible database, and visualised using TGAC?s genome browser. These data will be used to identify genes showing either sequence or expression variation associated with trait variation, for which molecular markers can then be developed for use in marker-assisted breeding.</gtr:abstractText><gtr:fund><gtr:end>2017-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2014-01-01</gtr:start><gtr:type>EXPENDITURE_PROJECTED</gtr:type><gtr:valuePounds>102453</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">BBS/E/T/000GP023</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>